Fundraising Fox
/Companies
Sign in

Nephros

NASDAQ: NEPH

River Edge, US · Delaware corporation

Find your way into Nephros

Sign up to see every warm intro you have to Nephros

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nephros team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Nephros is a point-of-use water filtration company that makes FDA-cleared micro- and ultrafilters to protect against Legionella and other waterborne pathogens, support dialysis water systems, and optimize beverage and ice equipment. It serves medical and commercial markets including hospitals, labs, dialysis providers, hotels, and food service, and runs a water-safety educational program.

CleantechHealthtechMedical Devices

Founders & leadership

DE
Daron EvansExecutive
RBRobert Banks
Robert BanksPresident and Chief Executive Officer
JKJudy Krandel
Judy KrandelChief Financial Officer

Board

PM
Paul MieyalBoard director
AA
Arthur AmronBoard director
MR
Matthew RosenbergBoard director
LC
Lawrence CentellaBoard director
MP
Malcolm PersenBoard director

Reported raises · per SEC filings

Form D private placements

$10.7M disclosed across 6 rounds · 2015–2021

▶$2.1MraisedSep 2021 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew AstorExecutive Officer, Director
  • Arthur AmronDirector
  • Oliver SpandowDirector
  • Thomas GwydirDirector
  • Alisa LaskDirector
Offering amount
$2.4M
Amount sold
$2.1M
Proceeds to insiders
$100K
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alisa LaskDirector
  • Andrew AstorExecutive Officer, Director
  • Thomas GwydirDirector
  • Arthur AmronDirector
  • Malcolm PersonDirector
  • Oliver SpandowDirector
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Jul 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2019 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daron EvansExecutive Officer, Director
  • Andrew AstorExecutive Officer
  • Paul A. MieyalDirector
  • Thomas GwydirDirector
  • Malcolm C. PersenDirector
  • Oliver SpandowDirector
  • Alisa LaskDirector
  • Arthur H. AmronDirector
Offering amount
$2M
Amount sold
$2M
Proceeds to insiders
$100K
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedSep 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Moshe PintoDirector
  • Malcolm PersenDirector
  • Paul MieyalDirector
  • Arthur AmronDirector
  • Oliver SpandowDirector
  • Daron EvansExecutive Officer, Director
  • Andrew AstorExecutive Officer
Offering amount
$10.2M
Amount sold
$1.3M
Proceeds to insiders
$100K
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedApr 2018 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daron EvansExecutive Officer, Director
  • Moshe PintoDirector
  • Malcolm PersenDirector
  • Andrew AstorExecutive Officer
  • Paul MieyalDirector
  • Arthur AmronDirector
Offering amount
$2.9M
Amount sold
$2.9M
Proceeds to insiders
$100K
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedMay 2015 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew RosenbergDirector
  • Lawrence CentellaDirector
  • Paul MieyalDirector
  • Daron EvansExecutive Officer, Director
  • Malcolm PersenDirector
  • Arthur AmronDirector
Offering amount
$1.5M
Amount sold
$1.2M
Proceeds to insiders
$100K
First sale
May 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Investors | Nephrosnephros.com · Feb 2022

Frequently asked questions

What does Nephros do?
Nephros is a point-of-use water filtration company that makes FDA-cleared micro- and ultrafilters to protect against Legionella and other waterborne pathogens, support dialysis water systems, and optimize beverage and ice equipment. It serves medical and commercial markets including hospitals, labs, dialysis providers, hotels, and food service, and runs a water-safety educational program.
How much funding has Nephros raised?
Nephros has disclosed $10.7M raised across 6 rounds.
Where is Nephros headquartered?
Nephros is headquartered in River Edge, US.